Elucidating mechanisms of cellular communication critical for head and neck cancer progression and metastasis.11/01/2023 - 10/31/2026 (Key Person / Mentor)
NIH/National Institute of Dental & Craniofacial Research1F31DE033292-01
Defining the Beta-catenin/CBP axis in head and neck cancer12/07/2020 - 11/30/2025 (Multi-PI)
PI:
Stefano Monti, PhDNIH/National Institute of Dental & Craniofacial Research5R01DE030350-04
Multiscale analysis of metabolic inflammation as a driver of breast cancer09/09/2020 - 08/31/2025 (Multi-PI)
PI:
Stefano Monti, PhDNIH/National Cancer Institute5U01CA243004-04
System-Level Analyses of Multi-Omics Data to Reveal Mechanisms of Head & Neck Cancer03/17/2022 - 01/31/2025 (PI)
NIH/National Institute of Dental & Craniofacial Research5R01DE031831-03
Novel genomic models to predict breast carcinogenicity of environmental chemicals10/01/2014 - 09/30/2024 (PI)
Art beCAUSE
Longevity Consortium: The role of molecular damage in muscle for muscle performance with aging06/01/2022 - 05/31/2024 (Subcontract PI)
Sutter Bay Hospitals dba California Pacific Medical Center NIH NIA5U19AG023122-15
Intercepting head and neck cancer using functional genomics approaches09/01/2020 - 08/31/2022 (Key Person / Mentor)
NIH/National Institute of Dental & Craniofacial Research5F31DE029701-02
Metabolic Pathways of Increased Cardiovascular risk in type 2 Diabetes04/01/2016 - 02/29/2020 (Subcontract PI)
Joslin Diabetes Center NIH NHLBI5R01HL132254-04
Lymphoma Target Testing Center07/01/2013 - 06/30/2016 (Subcontract PI)
Dana-Farber Cancer Institute Paul E. Singer Fdn
Receptor-based Developmental and Reproductive Toxicity of Superfund Chemicals09/20/2012 - 03/31/2016 (Co-Investigator)
PI:
David H. Sherr, PhDNIH/National Institute of Environmental Health Sciences5P42ES007381-19
Showing 10 of 11 results.
Show All Results
Targeting Genetically-driven p53 and Cell Cycle Deregulation in DLBCL10/01/2012 - 09/30/2015 (Subcontract PI)
Dana-Farber Cancer Institute Leukemia & Lymph Soc